6986 related articles for article (PubMed ID: 2444279)
1. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
2. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
3. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of several anthracyclines on mitochondrial respiration and coenzyme Q10 protection.
Solaini G; Ronca G; Bertelli A
Drugs Exp Clin Res; 1985; 11(8):533-7. PubMed ID: 3869924
[TBL] [Abstract][Full Text] [Related]
5. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
[TBL] [Abstract][Full Text] [Related]
6. Studies on the effects of anthracyclines on mitochondrial respiration in vitro.
Solaini G; Ronca G; Bertelli A
Drugs Exp Clin Res; 1985; 11(2):115-21. PubMed ID: 3869803
[TBL] [Abstract][Full Text] [Related]
7. Experimental studies on aclacinomycin.
Tone H; Nishida H; Takeuchi T; Umezawa H
Drugs Exp Clin Res; 1985; 11(1):9-15. PubMed ID: 2424701
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin, aclacinomycin and thepirubicin intracardiac distribution examined by fluorescence microscopy.
Scalori V; Alessandrì MG; Giovannini L; Bertelli AA; Mian M
Chemioterapia; 1988 Jun; 7(3):179-83. PubMed ID: 3168073
[TBL] [Abstract][Full Text] [Related]
9. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
Li ZR; Feng JB; Liang F; Zeng SX; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
[No Abstract] [Full Text] [Related]
10. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests.
Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H
Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017
[TBL] [Abstract][Full Text] [Related]
11. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
12. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
Burres NS; Myers MT; Sartorelli AC
Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
[TBL] [Abstract][Full Text] [Related]
13. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
Marie JP; Thevenin D; Zittoun R
Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics and action mechanism of anthracyclines].
Fukushima T; Ueda T; Nakamura T
Gan To Kagaku Ryoho; 1992 Apr; 19(4):445-50. PubMed ID: 1558393
[TBL] [Abstract][Full Text] [Related]
15. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
16. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
[No Abstract] [Full Text] [Related]
17. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
[TBL] [Abstract][Full Text] [Related]
18. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
Warrell RP
Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
[TBL] [Abstract][Full Text] [Related]
19. [Effect of aclacinomycin B on DNA polymerase II of tumor cells].
Li ZR; Feng JB; Han R; Yin MB; Xia LJ
Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):189-92. PubMed ID: 2943125
[No Abstract] [Full Text] [Related]
20. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]